Soligenix
SNGX
#10821
Rank
C$7.6 M
Marketcap
C$0.51
Share price
0.05%
Change (1 day)
-72.86%
Change (1 year)

Soligenix (SNGX) - Total debt

Total debt on the balance sheet as of March 2026 : C$0.46 Million

According to Soligenix's latest financial reports the company's total debt is C$0.46 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Soligenix - Total debt on balance sheet (from 1998 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$0.49 M-76.98%
2024-12-31C$2.13 M-54.03%
2023-12-31C$4.63 M-66.64%
2022-12-31C$13.89 M9.44%
2021-12-31C$12.69 M-5.22%
2020-12-31C$13.39 M7962.06%
2019-12-31C$0.16 M
2018-12-31N/A
2016-12-31N/A-100%
2015-12-31C$0.4 M-90.77%
2014-12-31C$4.39 M-50.11%
2013-12-31C$8.81 M
2004-12-31C$0.13 M-70.1%
2003-12-31C$0.46 M-59.6%
2002-12-31C$1.15 M233.74%
2001-12-31C$0.34 M-28.6%
2000-12-31C$0.48 M-14.47%
1999-12-31C$0.56 M-8.01%
1998-12-31C$0.61 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
C$77.45 B 16,629,368.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$89.76 B 19,273,474.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$32.64 B 7,007,914.27%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
C$26.16 M 5,518.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$23.81 B 5,113,007.12%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.80 B 173,371.24%๐Ÿ‡บ๐Ÿ‡ธ USA